Skip to main content
Premium Trial:

Request an Annual Quote

Hoechst Marion Roussel Research Building Opens

Premium

BRIDGEWATER, NJ--Pharmaceutical company Hoechst Marion Roussel announced the opening of a $45 million drug innovation facility that it said will double the company's research capacity here. The 150,000-square-foot facility will house 200 researchers dedicated to lead generation functions, including analytical and medicinal chemistry, automated chemical synthesis, biotechnology, automated screening, and molecular modeling.

Company spokesman Ron Rogers told BioInform the building will house a "significant" bioinformatics staff, but that Hoechst's major bioinformatics thrust is taking place in Cambridge, Mass., at the Hoechst-Ariad Research Center. Rogers said bioinformatics and knowledge management are important elements of Hoechst's strategy: "Everyone has access to technology. We think knowledge management will separate the winners from the losers."

Filed under

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.